Continuous Infusion May Improve the Efficacy of Vancomycin in Treatment of Experimental Endocarditis Due to Heterogeneous Vancomycin-Intermediate Staphylococcus aureus

Lignende værker

• Failure of Vancomycin Continuous Infusion against Experimental Endocarditis Due to Vancomycin-Intermediate Staphylococcus aureus
  af: Entenza, J. M., et al.
  Udgivet: (2011)
• Vancomycin Treatment Failure Associated with Heterogeneous Vancomycin-Intermediate Staphylococcus aureus in a Patient with Endocarditis and in the Rabbit Model of Endocarditis
  af: Moore, Matthew R., et al.
  Udgivet: (2003)
• Dosing Nomograms for Attaining Optimum Concentrations of Meropenem by Continuous Infusion in Critically Ill Patients with Severe Gram-Negative Infections: a Pharmacokinetics/Pharmacodynamics-Based Approach
  af: Pea, Federico, et al.
  Udgivet: (2012)
• Selection of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus by Imipenem
  af: Katayama, Yuki, et al.
  Udgivet: (2009)
• Heterogeneous vancomycin-intermediate among methicillin resistant Staphylococcus aureus
  af: Chaudhari, C.N., et al.
  Udgivet: (2014)